Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Diagnostic Nuclear Medicines is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. The research provides insights for the global Diagnostic Nuclear Medicines market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Diagnostic Nuclear Medicines industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Diagnostic Nuclear Medicines Market Segmentations:
By Players:
Lantheus
Nordion
Novartis
Eli Lilly
Navidea
Triad Isotopes
GE Healthcare
SIEMENS
Bracco Imaging
Curium Pharmaceuticals
China Isotope & Radiation
Dongcheng
Bayer
Jubilant Pharma
By Types:
Tc-99m
F-18
Other
By End-User:
Oncology
Cardiology
Other
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Diagnostic Nuclear Medicines Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m from 2014 to 2026
-
1.3.2 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18 from 2014 to 2026
-
1.3.3 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Oncology from 2014 to 2026
-
1.4.2 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Cardiology from 2014 to 2026
-
1.4.3 Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 Belgium Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Diagnostic Nuclear Medicines Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Diagnostic Nuclear Medicines by Major Types
-
3.4.1 Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m
-
3.4.2 Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18
-
3.4.3 Diagnostic Nuclear Medicines Market Size and Growth Rate of Other
4 Segmentation of Diagnostic Nuclear Medicines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Diagnostic Nuclear Medicines by Major End-Users
-
4.4.1 Market Size and Growth Rate of Diagnostic Nuclear Medicines in Oncology
-
4.4.2 Market Size and Growth Rate of Diagnostic Nuclear Medicines in Cardiology
-
4.4.3 Market Size and Growth Rate of Diagnostic Nuclear Medicines in Other
5 Market Analysis by Major Regions
-
5.1 Global Diagnostic Nuclear Medicines Production Analysis by Major Regions
-
5.2 Global Diagnostic Nuclear Medicines Consumption Analysis by Major Regions
-
5.3 Global Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
6 Product Commodity of Diagnostic Nuclear Medicines Market in Major Countries
-
6.1 Top 5 Export Countries in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.2 Top 5 Import Countries in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Diagnostic Nuclear Medicines Landscape Analysis
-
7.1 North America Diagnostic Nuclear Medicines Landscape Analysis by Major Types
-
7.2 North America Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users
-
7.3 North America Diagnostic Nuclear Medicines Landscape Analysis by Major Countries
-
7.3.1 United States Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
7.3.2 Canada Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
7.3.3 Mexico Diagnostic Nuclear Medicines Market Volume and Growth Rate
8 Europe Diagnostic Nuclear Medicines Landscape Analysis
-
8.1 Europe Diagnostic Nuclear Medicines Landscape Analysis by Major Types
-
8.2 Europe Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users
-
8.3 Europe Diagnostic Nuclear Medicines Landscape Analysis by Major Countries
-
8.3.1 Germany Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.2 UK Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.3 France Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.4 Italy Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.5 Nordic Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.6 Spain Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.7 Belgium Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.8 Poland Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.9 Russia Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
8.3.10 Turkey Diagnostic Nuclear Medicines Market Volume and Growth Rate
9 Asia Pacific Diagnostic Nuclear Medicines Landscape Analysis
-
9.1 Asia Pacific Diagnostic Nuclear Medicines Landscape Analysis by Major Types
-
9.2 Asia Pacific Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Diagnostic Nuclear Medicines Landscape Analysis by Major Countries
-
9.3.1 China Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
9.3.2 Japan Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
9.3.4 India Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
9.3.6 South Korea Diagnostic Nuclear Medicines Market Volume and Growth Rate
10 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Landscape Analysis
-
10.1 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Diagnostic Nuclear Medicines Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
10.3.2 Brazil Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
10.3.3 Nigeria Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
10.3.4 South Africa Diagnostic Nuclear Medicines Market Volume and Growth Rate
-
10.3.5 Argentina Diagnostic Nuclear Medicines Market Volume and Growth Rate
11 Major Players Profile
-
11.1 Lantheus
-
11.1.1 Lantheus Company Profile and Recent Development
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 Nordion
-
11.2.1 Nordion Company Profile and Recent Development
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 Novartis
-
11.3.1 Novartis Company Profile and Recent Development
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 Eli Lilly
-
11.4.1 Eli Lilly Company Profile and Recent Development
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Navidea
-
11.5.1 Navidea Company Profile and Recent Development
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 Triad Isotopes
-
11.6.1 Triad Isotopes Company Profile and Recent Development
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
-
11.7 GE Healthcare
-
11.7.1 GE Healthcare Company Profile and Recent Development
-
11.7.2 Market Performance
-
11.7.3 Product and Service Introduction
-
11.8 SIEMENS
-
11.8.1 SIEMENS Company Profile and Recent Development
-
11.8.2 Market Performance
-
11.8.3 Product and Service Introduction
-
11.9 Bracco Imaging
-
11.9.1 Bracco Imaging Company Profile and Recent Development
-
11.9.2 Market Performance
-
11.9.3 Product and Service Introduction
-
11.10 Curium Pharmaceuticals
-
11.10.1 Curium Pharmaceuticals Company Profile and Recent Development
-
11.10.2 Market Performance
-
11.10.3 Product and Service Introduction
-
11.11 China Isotope & Radiation
-
11.11.1 China Isotope & Radiation Company Profile and Recent Development
-
11.11.2 Market Performance
-
11.11.3 Product and Service Introduction
-
11.12 Dongcheng
-
11.12.1 Dongcheng Company Profile and Recent Development
-
11.12.2 Market Performance
-
11.12.3 Product and Service Introduction
-
11.13 Bayer
-
11.13.1 Bayer Company Profile and Recent Development
-
11.13.2 Market Performance
-
11.13.3 Product and Service Introduction
-
11.14 Jubilant Pharma
-
11.14.1 Jubilant Pharma Company Profile and Recent Development
-
11.14.2 Market Performance
-
11.14.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 94 Figures and 170 Tables)
-
Figure Product Picture
-
Figure Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m from 2014 to 2026
-
Figure Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18 from 2014 to 2026
-
Figure Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Oncology from 2014 to 2026
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Cardiology from 2014 to 2026
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Diagnostic Nuclear Medicines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Diagnostic Nuclear Medicines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Diagnostic Nuclear Medicines by Different Types from 2014 to 2026
-
Table Consumption Share of Diagnostic Nuclear Medicines by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of Tc-99m
-
Figure Market Size and Growth Rate of F-18
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Diagnostic Nuclear Medicines by Different End-Users from 2014 to 2026
-
Table Consumption Share of Diagnostic Nuclear Medicines by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Cardiology
-
Figure Market Size and Growth Rate of Other
-
Table Global Diagnostic Nuclear Medicines Production by Major Regions
-
Table Global Diagnostic Nuclear Medicines Production Share by Major Regions
-
Figure Global Diagnostic Nuclear Medicines Production Share by Major Regions in 2014
-
Figure Global Diagnostic Nuclear Medicines Production Share by Major Regions in 2018
-
Figure Global Diagnostic Nuclear Medicines Production Share by Major Regions in 2026
-
Table Global Diagnostic Nuclear Medicines Consumption by Major Regions
-
Table Global Diagnostic Nuclear Medicines Consumption Share by Major Regions
-
Figure Global Diagnostic Nuclear Medicines Consumption Share by Major Regions in 2014
-
Figure Global Diagnostic Nuclear Medicines Consumption Share by Major Regions in 2018
-
Figure Global Diagnostic Nuclear Medicines Consumption Share by Major Regions in 2026
-
Table North America Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Europe Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Diagnostic Nuclear Medicines market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table North America Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Types in 2014
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Types in 2018
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Types in 2026
-
Table North America Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table North America Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table North America Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table North America Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure North America Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure United States Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Types in 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Europe Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Europe Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure Germany Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure France Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Types in 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure China Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandDiagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure India Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Diagnostic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure GCC Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Company Profile and Development Status of Lantheus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus
-
Figure Sales and Growth Rate Analysis of Lantheus
-
Figure Revenue and Market Share Analysis of Lantheus
-
Table Product and Service Introduction of Lantheus
-
Table Company Profile and Development Status of Nordion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion
-
Figure Sales and Growth Rate Analysis of Nordion
-
Figure Revenue and Market Share Analysis of Nordion
-
Table Product and Service Introduction of Nordion
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Navidea
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea
-
Figure Sales and Growth Rate Analysis of Navidea
-
Figure Revenue and Market Share Analysis of Navidea
-
Table Product and Service Introduction of Navidea
-
Table Company Profile and Development Status of Triad Isotopes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes
-
Figure Sales and Growth Rate Analysis of Triad Isotopes
-
Figure Revenue and Market Share Analysis of Triad Isotopes
-
Table Product and Service Introduction of Triad Isotopes
-
Table Company Profile and Development Status of GE Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
-
Figure Sales and Growth Rate Analysis of GE Healthcare
-
Figure Revenue and Market Share Analysis of GE Healthcare
-
Table Product and Service Introduction of GE Healthcare
-
Table Company Profile and Development Status of SIEMENS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS
-
Figure Sales and Growth Rate Analysis of SIEMENS
-
Figure Revenue and Market Share Analysis of SIEMENS
-
Table Product and Service Introduction of SIEMENS
-
Table Company Profile and Development Status of Bracco Imaging
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging
-
Figure Sales and Growth Rate Analysis of Bracco Imaging
-
Figure Revenue and Market Share Analysis of Bracco Imaging
-
Table Product and Service Introduction of Bracco Imaging
-
Table Company Profile and Development Status of Curium Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Curium Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Curium Pharmaceuticals
-
Table Product and Service Introduction of Curium Pharmaceuticals
-
Table Company Profile and Development Status of China Isotope & Radiation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation
-
Figure Sales and Growth Rate Analysis of China Isotope & Radiation
-
Figure Revenue and Market Share Analysis of China Isotope & Radiation
-
Table Product and Service Introduction of China Isotope & Radiation
-
Table Company Profile and Development Status of Dongcheng
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng
-
Figure Sales and Growth Rate Analysis of Dongcheng
-
Figure Revenue and Market Share Analysis of Dongcheng
-
Table Product and Service Introduction of Dongcheng
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Jubilant Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma
-
Figure Sales and Growth Rate Analysis of Jubilant Pharma
-
Figure Revenue and Market Share Analysis of Jubilant Pharma
-
Table Product and Service Introduction of Jubilant Pharma
-
